Maximize Returns on Takeda Pharmaceutical Company Limited (each representing 1/2 of a share of) (TAK) Investments Using Our Online Dividend Calculator.
Takeda Pharmaceutical is Japan's largest pharmaceutical company, with revenue of JPY 4.3 trillion in fiscal 2023. The company's five core therapeutic areas are oncology, gastroenterology, neuroscience, rare diseases, and plasma-derived therapies, which account for more than 80% of revenue. Its geographic footprint is well diversified, with 50% derived from the US, 20% from Japan, 20% from Europe and Canada.
Stellantis N.V.
Franco-Nevada Corporation
Church & Dwight Company Inc.
America Movil S.A.B. de C.V. (each representing the right to receive twenty (20) Series B Shares
Las Vegas Sands Corp.
Hilton Worldwide Holdings Inc.
Banco Santander Brasil SA each representing one unit
Fomento Economico Mexicano S.A.B. de C.V.